Journal for ImmunoTherapy of Cancer (Nov 2023)
295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells
Abstract
No abstracts available.